B-type natriuretic peptide (BNP) attenuates the L-type calcium current and regulates ventricular myocyte function

Area of Science:

• Physiology
• Cardiovascular Biology
• Molecular Cardiology

Background:

• Hormonal regulation of cellular and organ function is a key physiological question.
• The role of natriuretic peptides, like BNP-32, in cardiac physiology is of significant interest.
• Understanding the specific mechanisms by which BNP-32 affects cardiac myocytes is crucial.

Purpose of the Study:

• To investigate the effects of BNP-32 on calcium handling in rat ventricular myocytes.
• To test the hypothesis that BNP-32 decreases the L-type calcium current (I(Ca,L)).
• To elucidate the molecular mechanisms underlying BNP-32's action on cardiac function.

Main Methods:

• Perforated patch clamp technique to record I(Ca,L) and action potentials (AP).
• Photodiode array edge-detection system for myocyte shortening measurements.
• Fluorescence photometry for intracellular calcium transient analysis and Western blotting for protein expression.

Main Results:

• BNP-32 decreased cell shortening, reduced I(Ca,L) amplitude and Ca(2+)-dependent inactivation, and altered AP characteristics.
• BNP-32 significantly decreased intracellular calcium transient amplitude while increasing its time to peak.
• BNP-32 reduced sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2a) protein expression.

Conclusions:

• BNP-32 regulates ventricular myocyte function by attenuating I(Ca,L) and altering the AP.
• BNP-32 reduces SERCA2a activity and/or expression, impacting calcium reuptake.
• This study reveals a novel autocrine mechanism for BNP-32's action on L-type calcium channels in ventricular myocytes.